Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 7 months after Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Emotional respons...

By: Neurogen Brain and Spine Institute

Visit link:
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2 - Video

Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. Part 2
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Ball throw...

By: Neurogen Brain and Spine Institute

Continue reading here:
Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. Part 2 - Video

DUBLIN, July 16, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/dhdp3r/cell_therapy) has announced the addition of Jain PharmaBiotech's new report "Cell Therapy - Technologies, Markets and Companies" to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice.

Stem cells are discussed in detail in one chapter. Some light is thrown on the current controversy of embryonic sources of stem cells and comparison with adult sources. Other sources of stem cells such as the placenta, cord blood and fat removed by liposuction are also discussed. Stem cells can also be genetically modified prior to transplantation.

Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine. Pharmaceutical applications of stem cells including those in drug discovery are also described. Various types of cells used, methods of preparation and culture, encapsulation and genetic engineering of cells are discussed. Sources of cells, both human and animal (xenotransplantation) are discussed. Methods of delivery of cell therapy range from injections to surgical implantation using special devices.

Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous system and cancer which are the topics for separate chapters. Other applications include cardiac disorders (myocardial infarction and heart failure), diabetes mellitus, diseases of bones and joints, genetic disorders, and wounds of the skin and soft tissues.

Regulatory and ethical issues involving cell therapy are important and are discussed. Current political debate on the use of stem cells from embryonic sources (hESCs) is also presented. Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.

The cell-based markets were analyzed for 2012, and projected to 2022. The markets are analyzed according to therapeutic categories, technologies and geographical areas. The largest expansion will be in diseases of the central nervous system, cancer and cardiovascular disorders. Skin and soft tissue repair as well as diabetes mellitus will be other major markets.

The number of companies involved in cell therapy has increased remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 287 of these are profiled in part II of the report along with tabulation of 273 alliances. Of these companies, 158 are involved in stem cells. Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations. The text is supplemented with 55 Tables and 12 Figures. The bibliography contains 1,050 selected references, which are cited in the text.

Read more here:
Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles

stem cell therapy for Sports injuries.
Videos is about the Stem Cell Treatment provided to various athletes and sports persons. Dr. Purita had provided treatment for the knee, elbow, shoulder, wri...

By: Stem Md

Read the original here:
stem cell therapy for Sports injuries. - Video

Life stem cell therapy Purtier
9 years old girl benefited from deer placenta.

By: Keith Chew

Continued here:
Life stem cell therapy Purtier - Video

Wisconsin Alumni Research Foundation ranks fourth in biotechnology patents 77Square.com Bioentrepreneur, a website affiliated with the journal Nature, has ranked UW-Madison's Wisconsin Alumni Research Foundation (WARF) the fourth-most-active entity in biotechnology patents issued in the U.S. and Europe from 2008 to 2012. In that span ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGQOLEBzDDMnFMht0qfe1OUoFdLNg&url=http://host.madison.com/wsj/news/local/education/university/wisconsin-alumni-research-foundation-ranks-fourth-in-biotechnology-patents/article_ceb5524f-8c64-5bae-98d4-5fd7e9450524.html

Boston Globe

Is Alynlam the next breakthrough name in biotechnology? Investors say 'yes' MedCity News (Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the Cambridge, Massachusetts-based company ... Stocks to Keep Your Eyes on - Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN ...Techsonian Alnylam Pharmaceuticals (ALNY) Shares Soar After Positive Drug Trial ResultsNew Stuff Here Alnylam Reports Positive Top-Line Results for ALN-TTRsc, a Subcutaneously ...EON: Enhanced Online News (press release) all 32 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEz5ensUYZAz22zl7md7KPcZtVDCQ&url=http://medcitynews.com/2013/07/is-alynlam-the-next-breakthrough-name-in-biotechnology-investors-say-yes/

ThyssenKrupp inaugurated biotechnology in Leuna SteelGuru Dr. Heinrich Hiesinger CEO of ThyssenKrupp said that “Modern biotechnology is one of the key technologies of the 21st century. Biotechnological processes, products and services play a role in almost all areas of our daily lives for example in the ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFOL_CVTfJ5-xATaVosty46SZpARQ&url=http://www.steelguru.com/international_news/ThyssenKrupp_inaugurated_biotechnology_in_Leuna/318694.html

The Express Tribune

Genetic Engineering, Biotechnology and the Future Of Humanity Center for Research on Globalization In the UK, Genewatch UK has revealed how Monsanto, Syngenta, Bayer, and BASF (all biotech companies) under the guise of the 'Agricultural Biotechnology Council' held a meeting in June 2012 with government ministers and academics to formulate a ... Agricultural sector promotes biotechnologyThe Express Tribune Food Minister for using biotechnology to reduce food insecurityPakistanToday.com.pk all 6 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH-TAOiYDgt-zLnE1DtCjTTRd-oxA&url=http://www.globalresearch.ca/genetic-engineering-biotechnology-and-the-future-of-humanity/5342175

First microRNA mimic enters clinic Nature.com Nature Biotechnology. Full text access provided to Google by Bot. Cart. Search Go Advanced search · nature.com · journal home · current issue · News; full text. Nature Biotechnology | News. Print; Email; Share/bookmark. Cite U Like · Facebook · Twitter ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEWC47_z_Yfzc3MAnDapCvGvlkARQ&url=http://www.nature.com/nbt/journal/v31/n7/full/nbt0713-577.html

Common food supplement fights degenerative brain disorders Heritage Florida Jewish News A team headed by professor Gil Ast and Dr. Ron Bochner of Tel Aviv University's department of human molecular genetics decided to test whether the same chemical, which is naturally synthesized in the body and known to boost memory capability, could ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGB0hFEVhN5otgMVSVBw3NoLDFzgg&url=http://www.heritagefl.com/story/2013/07/12/features/common-food-supplement-fights-degenerative-brain-disorders/1054.html

Study cracks universal RNA code, suggests a new cause for autism Phys.Org "This was a surprising finding, because we knew RBFOX1 controls gene expression, but had no idea it also stabilizes RNA," said Tim Hughes, a Professor in the Department of Molecular Genetics and the Donnelly Centre. "It's a good example of the ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG5CdrVKBW-YXAYzsj6bvD5o9eKcA&url=http://phys.org/wire-news/135086764/study-cracks-universal-rna-code-suggests-a-new-cause-for-autism.html

BioNews Texas

UT Southwestern Medical Center Scientists' Discovery Of Rare Gene Mutation ... BioNews Texas ... Development, UT Southwestern and Investigator, Howard Hughes Medical Institute, UT Southwestern; and Dr. Helen H. Hobbs, Professor, Department of Medicine Department of Molecular Genetics at the University of Texas Southwestern Medical Center in ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHnzOaBoXQjWRlw2V8NzRZARxfTwA&url=http://bionews-tx.com/news/2013/07/12/ut-southwestern-medical-center-scientists-discovery-of-rare-gene-mutation-ignites-anti-cholesterol-drug-development-race/

Is There A Sickle Cell Cure? Lasentinel “We're publishing a paper describing some pre-clinical studies that we've been doing over the last three years,” said Dr. Donald Kohn, M.D. professor at UCLA, department of microbiology, immunology, and molecular genetics, the department of pediatrics ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE5o9O8JNRXwEzof9MD7-48Yb6QNw&url=http://www.lasentinel.net/index.php?option%3Dcom_content%26view%3Darticle%26id%3D11450:is-there-a-sickle-cell-cure%26catid%3D80:local%26Itemid%3D170

Jon Shestack(l) with J.T. Thomas, chairman of CIRM, at a 2012 board meeting California Stem Cell Report photo

“Over eight years there were moments
that were inspiring, some were contentious, and there was a bruising
number of meetings but through it all, the board was involved,
passionate and, will forever be for me, the gold standard when it
comes to integrity.
“The same goes double for the staff –
truly the most excellent, devoted, committed group of people I
have ever had the pleasure of working with.”

“When I started at CIRM, my sweet son
with autism was 12. Now he is 21. Over eight years our family has
learned more about how many are the challenges that await him and how
few the opportunities he has to look forward to. We have seen his
world get smaller and smaller. While my son is special to me. He is
not unique. There are thousands and thousands affected by mental
illness who need a better life.
“Sometimes feel that I have failed
these people, in particular those affected by autism or cerebral
palsy. Though CIRM ran first-rate workshops on these disorders, we
did not do all we could to follow up, put out disease-specific RFAs
and get in proposals that addressed the workshop recommendations. I
wish I had been more persuasive."

“In the movies, the third act is
where the hero takes stock of all the previous wins and losses, all
the hardships and lessons learned, and she puts all that knowledge
together in new, and surprising ways until victory is within reach!
As CIRM enters its third act, I hope it will do the same. I hope it
will challenge itself, always put the urgency of the mission
ahead of everything else and be willing to question the policies that
have been so successful in the past, and consider that new ones may
be needed for the future.
“And this is the future as I see it
for CIRM. We will have faith, but we will continue to earn our
miracles We will use our hearts and our minds to rip those miracles
out of the dreamy future and make them real today. We will seek out
the best scientists and encourage them to use all their wisdom, art
and discernment to bring us cures. And when we have done that, we
will do it again the next day. We will be optimistic, but not
satisfied. We will question authority, despise complacency and above
all love those among us in need of healing--this is the obligation
without end, whose reward is also without end.”

Shestack
Resignation Letter

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/BaaZlqP9Q4s/shestack-resignation-letter-heartfelt.html

“Six months (after providing the
eggs) my body began to fail me. I had always been a healthy and
active woman, but suddenly I was crippled by pain and unable to live
the life I had once enjoyed. I was soon diagnosed with stage IV
endometriosis, a disease my doctors now believe was pushed into
overdrive as a result of the potent hormones involved in my egg
donation protocols.”

“AB 926 may open the doors for
increased fertility research, but the potential costs for women’s
lives and health far outweigh any compensation that could ever be
offered.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/uMnWUVrymr8/tv-news-piece-on-pay-for-eggs-airs-in.html

Al Rowlett Turning Point photo

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/C2aH568yoco/sacramento-mental-health-advocate.html

“If you agree that more research on
short- and long-term risks is needed before expanding the market for
women’s eggs, please act quickly. Contact Governor Brown and ask
him to veto AB926.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/OqoMeSiIO_c/veto-campaign-launched-on-california.html

“In the last 6 months, though, the
industry has seen a tremendous rebound, with almost twice that number
of IPOs in half the time. And there's no sign that the great leap
into the public market is waning, with 10 more IPOs in the queue.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/g8tqW1ynaMw/comfort-news-for-californias-stem-cell.html

“(C)omplicating the issue is
California’s role as a national leader in stem cell research, the
existential question of who or what constitutes a research subject,
and finally, the fact that compensation for fertility purposes is and
has been legal for years in California.”

Lisa Ikemoto UC Davis photo

“On the fertility side, it’s
politically hard to touch because it’s all around family formation.
Nobody wants to restrict family formation. On the research side, when
the issue of payment for eggs came up, it was connected with human
embryonic stem cell research, and human embryonic stem cell research
was politicized from the outset.”

“Groups that fundamentally oppose
stem cell research such as the California Catholic Conference and
other pro-life groups are natural opponents of the bill, but they are
joined by a number of pro-choice groups who expressed concerns over
the limited research on the effects of egg donation on women’s
health.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/pskHpPceyco/pay-for-eggs-legislation-strange.html